Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (between 59°F to 86°F). Brief exposure to temperatures up to 40°C (104°F) may be tolerated provided the mean kinetic temperature does not exceed 25°C (77°F); however, such exposure should be minimized.
This product is to be used as directed by a physician and should not be used to treat any condition other than that for which it was prescribed. If redness or irritation occurs, discontinue use and consult a physician.
This product is a keratolytic emollient which is a gentle, yet potent, tissue softener for skin.
Each gram contains 390 mg of urea in a vehicle consisting of: carbomer, cetyl alcohol, dimethyl isosorbide, glyceryl stearate, mineral oil, petrolatum, propylene glycol, sodium hydroxide, water, and xanthan gum.
Urea is a diamide of carbonic acid with the following chemical structure:
Urea gently dissolves the intercellular matrix which results in loosening the horny layer of skin and shedding scaly skin at regular intervals, thereby softening hyperkeratotic areas of the skin.
The mechanism of action of topically applied urea is not yet known.
This product is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, xerosis, ichthyosis, skin cracks and fissures, dermatitis, eczema, psoriasis, keratoses and calluses.
This product is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product.
KEEP OUT OF REACH OF CHILDREN.
FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE.
Patients should discontinue the use of this product if the condition becomes worse or if a rash develops in the area being treated or
elsewhere. Avoid contact with eyes, lips and mucous membranes.
Long-term animal studies for carcinogenic potential have not been performed on this product to date. Studies on reproduction and fertility also have not been performed.
Category C.Animal reproduction studies have not been conducted with this product. It is also not known whether this product can affect reproduction capacity or cause fetal harm when administered to a pregnant woman. This product should be used by a pregnant woman only if clearly needed or when potential benefits outweigh potential hazards to the fetus.
It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when this product is administered to a nursing woman.
Transient stinging, burning, itching or irritation may occur and normally disappear upon discontinuing the use of this product.
Apply to affected area(s) twice per day or as directed by a physician. Rub in until completely absorbed.
Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (between 59°F to 86°F). Brief exposure to
temperatures up to 40°C (104°F) may be tolerated provided the mean kinetic temperature does not exceed 25°C (77°F); however, such exposure should be minimized.
Protect from freezing and excessive heat. Keep bottle tightly closed.
8 oz. (227 g) bottles, NDC 44523-801-08
To reporta serious adverse event or obtain product information, call (866) 762-2365.
Manufactured for:
BIOCOMP PHARMA, INC.
San Antonio, TX 78230 1355
2100669 [00] R1021
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 44523-801-08 | 2024-03-06 | C162847 | 48780-1 | 1030e365-5bc4-111a-e063-dadaa90a10e2 | UREA CREAM 39% |
| 44523-801-08 | 2024-01-30 | C162847 | 48780-1 | 1030e365-5bc4-111a-e063-dadaa90a10e2 | UREA CREAM 39% |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 44523-801-08 | Urea 39% Cream | 227 g in 1 BOTTLE | CREAM | 227 | 3 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 44523-801-08 | GM - Gram | 44523-801 | b01b6262-a573-437c-9295-23f89ec58cd7 | 1 | 2022-11-07 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 44523-801 | 44523-801-08 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| MINERAL OIL | T5L8T28FGP | IACT |
| PETROLATUM | 4T6H12BN9U | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| WATER | 059QF0KO0R | IACT |
| GLYCERYL MONOSTEARATE | 230OU9XXE4 | IACT |
| XANTHAN GUM | TTV12P4NEE | IACT |
| DIMETHYL ISOSORBIDE | SA6A6V432S | IACT |
| CARBOMER INTERPOLYMER TYPE A (55000 CPS) | 59TL3WG5CO | IACT |
| CETYL ALCOHOL | 936JST6JCN | IACT |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
| UREA | 8W8T17847W | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Urea 39% Cream | UREA 39% CREAM | BioComp Pharma, Inc. | e79004b9-ffbc-3d06-e053-2995a90a8cd7 | 2026-01-13 | Warnings, Adverse reactions | 44523-801-08 44523-801 44523080108 4846ec49-3653-db3d-e063-6294a90aa815 e79004b9-ffbc-3d06-e053-2995a90a8cd7 |
Adverse event summaries are temporarily unavailable. Other product information remains available.